RxSight, Inc. - Common Stock, par value $0.001 per share (RXST)

CUSIP: 78349D107

Q2 2024 13F Holders as of 30 Jun 2024

Holder snapshot 7 signals
Share change
+2,354,190
Put/Call ratio
22%
SEC-reported price per share
$60.17
Number of holders
226
Value change
+$144,187,015
Number of buys
122
Open additional details 1 more signal available
Number of sells
99
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
41,457,800

Security key

78349D107

Report period

Q2 2024

Institutions

226

Top holders

10

Ownership snapshot

Top reported holders of RXST - RxSight, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
0/15
Latest evidence
31 Mar 2024
13F 3/4/5 Highest disclosed value: $177,580,914 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. has the largest disclosed position value at $177.58M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Disclosed position value Top 5
RA CAPITAL MANAGEMENT, L.P. $177.58M
RxSight I, LLC $96.81M
BlackRock Finance, Inc. $108.81M
Artisan Partners Limited Partnership $97.78M
LORD, ABBETT & CO. LLC $91.42M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
13F 3/4/5
Company · 10%+ Owner
—
denominator unverified
$177,580,914
3,442,825 shares
— 31 Mar 2024
RxSight I, LLC
3/4/5
10%+ Owner
—
denominator unverified
$96,806,554
2,016,778 shares
— 03 Aug 2021
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$108,811,053
2,109,559 shares
— 31 Mar 2024
Artisan Partners Limited Partnership
13F
Company
13F
—
denominator unverified
$97,782,321
1,895,741 shares
— 31 Mar 2024
LORD, ABBETT & CO. LLC
13F
Company
13F
—
denominator unverified
$91,420,000
1,772,390 shares
— 31 Mar 2024
Richard M. Wolfen
3/4/5
Director
—
denominator unverified
$88,332,816
1,840,244 shares
— 03 Aug 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
226
Shares
32,949,059
Rows available
226
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
194
Q2 2024 holders
226
Holder diff
32
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .